Capitalization 11,271B 73.21B 101B P/E ratio 2025 *
55.7x
P/E ratio 2026 * 43.5x
Enterprise value 8,614B 55.95B 77.11B EV / Sales 2025 *
5.79x
EV / Sales 2026 * 4.93x
Free-Float
97.04%
Yield 2025 *
1.02%
Yield 2026 * 1.25%
More valuation ratios * Estimated data
Dynamic Chart

Last Transcript: Daiichi Sankyo Co., Ltd.

1 day+0.64%
1 week-2.16%
Current month+7.57%
1 month+9.19%
3 months+25.65%
6 months+36.91%
Current year+53.46%
More quotes
1 week
5 800.00
Extreme 5800
6 055.00
1 month
5 359.00
Extreme 5359
6 109.00
Current year
3 847.00
Extreme 3847
6 109.00
1 year
3 566.00
Extreme 3566
6 109.00
3 years
1 981.00
Extreme 1981
6 109.00
5 years
1 731.00
Extreme 1731
6 109.00
10 years
518.67
Extreme 518.6667
6 109.00
More quotes
Insider TitleAgeSince
Chief Executive Officer 69 07-03-31
President 61 17-03-31
Chief Tech/Sci/R&D Officer - 21-03-31
Insider TitleAgeSince
Chief Executive Officer 69 07-03-31
Director/Board Member 75 19-05-31
Director/Board Member 66 19-05-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.64%-2.16%+44.86%+163.33% 72.24B
+1.42%-6.72%+90.09%+259.73% 791B
-1.15%-1.20%+65.09%+223.71% 595B
-1.23%+0.89%-10.48%-11.32% 367B
-1.04%-0.85%+12.67%+60.41% 315B
-0.26%+2.33%+20.46%+46.50% 306B
-0.05%-0.73%-0.55%-21.06% 247B
-0.57%-1.40%+11.99%+45.59% 244B
-0.69%-4.13%+4.59%+13.72% 218B
-0.81%+0.03%+41.91%+34.52% 179B
Average -0.77%-0.75%+28.06%+81.51% 333.38B
Weighted average by Cap. -0.92%-1.99%+39.27%+118.33%
See all sector performances

Financials

Ratios2025 *2026 *
Net sales 1,800B 11.69B 16.11B 2,101B 13.65B 18.81B
Net income 202B 1.31B 1.81B 258B 1.68B 2.31B
Net Debt -858B -5.57B -7.68B -911B -5.92B -8.15B
More financial data * Estimated data
Logo Daiichi Sankyo Co., Ltd.
Daiichi Sankyo Company specializes in developing, manufacturing and marketing pharmaceutical products. Net sales break down by activity as follows: - sale of medicines (99.8%): prescription medicines (92.8% of net sales) and OTC medicines (7.2%) primarily for the treatment of thrombotic disorders, tumors, diabetes and rheumatoid arthritis; - other (0.2%): primarily real estate activities. Net sales are distributed geographically as follows: Japan (64.1%), North America (17.2%), Europe (9.7%) and other (9%).
Employees
18,726
Calendar
Related indices
More about the company
Date Price Change Volume
24-07-24 5,942.00 ¥ +0.64% 2 841 100
24-07-23 5,904.00 ¥ +0.85% 2,523,200
24-07-22 5,854.00 ¥ -0.90% 2,750,300
24-07-19 5,907.00 ¥ -0.71% 3,518,700
24-07-18 5,949.00 ¥ -2.04% 2,992,900

Delayed Quote Japan Exchange, July 24, 2024 at 02:00 am

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
5,904.00JPY
Average target price
6,306.25JPY
Spread / Average Target
+6.81%
Consensus